Industry

From molecule to patient, faster.

195 Global Consulting
Overview

From molecule to patient, faster.

Pharmaceutical, biotech and medtech leaders work with us to sharpen R&D productivity, launch with impact and build commercial models fit for precision medicine.

Scientific breakthroughs in biologics, cell and gene therapy and AI-driven discovery are colliding with pricing pressure and patent cliffs. Companies that pick the right assets, run efficient trials and launch with precision will lead the next decade.

Our life sciences team brings together sector specialists, data scientists and implementation experts, working as one team with clients from the boardroom to the front line.

Questions we help answer
  1. 01Which assets in our pipeline deserve more investment, and which should we partner or stop?
  2. 02How can we cut trial timelines and cost without compromising evidence?
  3. 03What does an excellent launch look like in an access-constrained market?
How we help clients

6 areas where our industry teams bring deep expertise, proven methods and hands-on support.

We help companies prioritise their pipelines, design efficient trials and apply AI to discovery and development. More of the right medicines reach patients sooner.

We plan launches around market access, evidence and omnichannel engagement with healthcare professionals. Launch trajectories become faster and more predictable.

We build value stories and pricing strategies that work for payers and patients. Access is secured across diverse health systems.

We strengthen quality, capacity planning and technology transfer, particularly for biologics and advanced therapies. Supply becomes reliable as products scale.

We help medical-technology companies grow through innovation, commercial excellence and service models. Products and services are designed around clinical value.

We assess assets, structure partnerships and support integration. Deals are judged on scientific, commercial and operational merit.

Impact

9 mo
Average cycle-time reduction
120+
Product launches supported
$8B
Deal value assessed
Work with us

Tell us about the decision in front of you. A senior partner will respond within one business day.

Start a conversation